Resultados da pesquisa

Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB Por Christiane Gerke, Anna Colucci, Carlo Giannelli, Silvia Sanzone, Claudia Giorgina Vitali, Luigi Sollai, Omar Rossi, Laura B. Martin, Jochen Auerbach, Vito Di Cioccio, Allan Saul

Obter o texto integral Obter o texto integral

Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting Por Adam Penn‐Nicholson, Hennie Geldenhuys, Wivine Burny, Robbert van der Most, Cheryl L. Day, Erik Jongert, Philippe Moris, Mark Hatherill, Opokua Ofori‐Anyinam, Willem A. Hanekom, Anne Bollaerts, Marie‐Ange Demoitié, Angelique Kany Kany Luabeya, Evi De Ruymaeker, Michèle Tameris, Didier Lapierre, Thomas J. Scriba

Obter o texto integral

Application of “Systems Vaccinology” to Evaluate Inflammation and Reactogenicity of Adjuvanted Preventative Vaccines Por D. J. Lewis, Mark P. Lythgoe

Obter o texto integral Obter o texto integral

Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: A phase III, randomized, multicentre, lot-to-lot consistency study Por Kirsten P. Perrett, Jodie McVernon, Peter Richmond, Helen Marshall, Michael D. Nissen, Allison August, Sandra Percell, Daniela Toneatto, Terry Nolan

Obter o texto integral

Safety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adults Por Manon Cox, Ruvim Izikson, Penny Post, Lisa M. Dunkle

Obter o texto integral Obter o texto integral

Safety and immunogenicity of an investigational 4-component<i>Staphylococcus aureus</i>vaccine with or without AS03_Badjuvant: Results of a randomized phase I trial Por Jack Lévy, Laurent Licini, Edwige Haelterman, Philippe Moris, Pascal Lestrate, Silvia Damaso, Pascale Van Belle, Dominique Boutriau

Obter o texto integral Obter o texto integral

Efficacy and safety of praziquantel for the treatment of human schistosomiasis during pregnancy: a phase 2, randomised, double-blind, placebo-controlled trial Por Remigio M. Olveda, Luz P. Acosta, Veronica Tallo, Palmera Baltazar, Jenny Lind S Lesiguez, Georgette G Estanislao, Edna B. Ayaso, Donna Bella S. Monterde, Antonio Ida, Nora L. Watson, Emily A. McDonald, Hannah Wu, Jonathan D. Kurtis, Jennifer F. Friedman

Obter o texto integral

Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs Por Nikolai Petrovsky

Obter o texto integral Obter o texto integral

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in gi... Por Ting Fan Leung, Anthony Pak‐Yin Liu, Fong Seng Lim, Franck Thollot, Helen May Lin Oh, Bee Wah Lee, Lars Rombo, Ngiap Chuan Tan, Roman Rouzier, Damien Friel, Benoit De Muynck, Stéphanie De Simoni, P.V. Suryakiran, Marjan Hezareh, Nicolas Folschweiller, Florence Thomas, Frank Struyf

Obter o texto integral Obter o texto integral

A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I) Por Roman Prymula, Susanna Esposito, Gian Vincenzo Zuccotti, Fang Xie, Daniela Toneatto, Igor Kohl, Peter Dull

Obter o texto integral

Safety and Immunogenicity of the Malaria Vaccine Candidate MSP3 Long Synthetic Peptide in 12–24 Months-Old Burkinabe Children Por Sodiomon B. Sirima, Alfred B. Tiono, Alphonse Ouédraogo, Amidou Diarra, André Lin Ouédraogo, Jean Baptiste Yaro, Espérance Ouédraogo, Adama Gansané, Edith C. Bougouma, Amadou T. Konaté, Youssouf Kaboré, Abdoulaye Traoré, Roma Chilengi, Issiaka Soulama, Adrian J. F. Luty, Simon Cousens, Issa Nébié

Obter o texto integral Obter o texto integral

Phase I Safety and Immunogenicity Evaluation of MVA-CMDR, a Multigenic, Recombinant Modified Vaccinia Ankara-HIV-1 Vaccine Candidate Por Jeffrey R. Currier, Viseth Ngauy, Mark de Souza, Silvia Ratto‐Kim, Josephine H. Cox, Victoria R. Polonis, Patricia L. Earl, Bernard Moss, Sheila A. Peel, Bonnie M. Slike, Somchai Sriplienchan, P Thongcharoen, Robert Paris, Merlin L. Robb, Jérôme H. Kim, Nelson L. Michael, Mary Marovich

Obter o texto integral Obter o texto integral

Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: A phase I/II randomized clinical study Por Geert Leroux‐Roels, Cathy Maes, Fien De Boever, Magali Traskine, J. Rüggeberg, Dorota Borys

Obter o texto integral

A Phase 1 Trial of MSP2-C1, a Blood-Stage Malaria Vaccine Containing 2 Isoforms of MSP2 Formulated with Montanide® ISA 720 Por James McCarthy, Joanne Marjason, Suzanne Elliott, Paul Fahey, Gilles Bang, Elissa Malkin, E L Tierney, Hayley Aked-Hurditch, Christopher G. Adda, Nadia Cross, Jack S. Richards, Freya J. I. Fowkes, Michelle J. Boyle, Carole A. Long, Pierre Druilhe, James G. Beeson, Robin F. Anders

Obter o texto integral Obter o texto integral

Priming Effect of Dengue and Yellow Fever Vaccination on the Immunogenicity, Infectivity, and Safety of a Tetravalent Dengue Vaccine in Humans Por Ming Qiao, David R. Shaw, Rémi Forrat, Anh Wartel-Tram, Jean Lang

Obter o texto integral Obter o texto integral

Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial Por Paul Spearman, Spyros A. Kalams, Marnie Elizaga, Barbara Metch, Ya-Lin Chiu, Mary Allen, Kent J. Weinhold, Guido Ferrari, Scott Parker, M. Juliana McElrath, Sharon E. Frey, Jonathan Fuchs, Michael C. Keefer, Michael D. Lubeck, Michael A. Egan, Ralph P. Braun, John H. Eldridge, Barton F. Haynes, Lawrence Corey

Obter o texto integral

Intradermal Influenza Vaccine Administered Using a New Microinjection System Produces Superior Immunogenicity in Elderly Adults: A Randomized Controlled Trial Por David J. Holland, Robert Booy, Ferdinandus de Looze, Peter Eizenberg, James McDonald, Jeff Karrasch, Maureen McKeirnan, Hatem H. Salem, Graham Mills, Jim Reid, Françoise Weber, Mélanie Saville

Obter o texto integral Obter o texto integral

Safety and Reactogenicity of Canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E Vaccination in an Efficacy Trial in Thailand Por Punnee Pitisuttithum, Supachai Rerks‐Ngarm, Valai Bussaratid, Jittima Dhitavat, Wirach Maek-a-nantawat, Swangjai Pungpak, Pravan Suntharasamai, S Vanijanonta, Sorachai Nitayapan, Jaranit Kaewkungwal, Michael W. Benenson, Patricia Morgan, Robert J. O’Connell, Jeffrey L. Berenberg, Sanjay Gurunathan, Donald P. Francis, Robert Paris, Joseph Chiu, Donald M. Stablein, Nelson L. Michael, Jean‐Louis Excler, Merlin L. Robb, Jérôme H. Kim

Obter o texto integral Obter o texto integral

Safety and Tolerability of Conserved Region Vaccines Vectored by Plasmid DNA, Simian Adenovirus and Modified Vaccinia Virus Ankara Administered to Human Immunodeficiency Virus Type... Por E Hayton, Annie Rose, Umar Ibrahimsa, Mariarosaria Del Sorbo, Stefania Capone, Alison Crook, Antony P. Black, Lucy Dorrell, Tomáš Hanke

Obter o texto integral Obter o texto integral

High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants Por Xinyuan Chen, Marco Pravetoni, Brijesh Bhayana, Paul R. Pentel, Mei X. Wu

Obter o texto integral